Radiopharmaceutical Therapy Part 1: Safety Aspects for Dispensing Alpha and Beta Radioisotopes


New therapeutic radiopharmaceuticals—especially those that decay by emitting alpha or beta particles—pose distinct challenges for radiopharmacy. Learn the physical characteristics of radioisotopes used for therapy and discover how the new particulate emitters affect the radiopharmacy practice, specifically in the areas of radiation safety, dose calibration, and distribution in a U.S. Pharmacopeia General Chapter environment.

Pharmacist Learning Objectives

At the completion of this knowledge-based activity, participants will be able to: 

  1. Describe the difference between particulate and high gamma decay in therapy. 
  2. Explain the different safety techniques for handling and dispensing particulate and high levels of gamma-emitting isotope.


This activity is approved for Board Certified Nuclear Pharmacists (BCNP) recertification credits.

William Erwin,
Senior Medical Physicist
UT MD Anderson Cancer Center
George Kourlas, Pharm D ANP BCNP
Nuclear Pharmacist
Memorial Sloan Kettering Cancer Center
Learning Level: Level 2
Track: Nuclear Pharmacy
Session Time Slot(s): 
Sunday, March 18
1:00 PM - 3:00 PM
Music City Center - Room 105A
ACPE Pharmacist: 0202-0000-18-079-L05-P
CEUs Pharmacist: 0.2
Activity Type: